In this inaugural episode of The Genomics Revolution, host Sian Jarvis is joined by Professor Sir Peter Donnelly, a leading expert in genomics and the founder of Genomics Ltd.

Together, they discuss the transformative impact of genomics on drug discovery and healthcare, exploring how genetic insights can lead to more personalised medicine and improved health outcomes.

From understanding individual disease risks to enhancing drug development success rates, this episode uncovers the revolutionary potential of genomics in reshaping our approach to drug development.

For more information, visit Genomics: https://genomics.com/

Chapters:

(00:00) Genomics Revolution explores how genomics can transform health and drug discovery

(03:41) 95% of drugs fail during drug development process, according to research

(09:42) You talked about how genomics can help drug discovery

(13:19) Why is there so much hesitation around the adoption of genomics

(17:00) How can we use genomics to improve health outcomes

(24:45) Next step is to roll out these technologies in cardiovascular prevention

(25:29) Genetics is a major driver of the likelihood of a person becoming obese